December 1st 2020, 11:06pm
Managed care pharmacists can influence several aspects of care in Parkinson disease, particularly through determining clinical pathways and educating patients and providers on novel agents coming to market.
November 27th 2020, 3:00pm
Low-frequency transcranial stimulation of the pre-supplementary motor area was found to delay the onset and reduce severity of levodopa-induced dyskinesia in patients with Parkinson disease.
November 23rd 2020, 8:00pm
An eye exam paired with artificial intelligence machine learning technology may provide a novel approach to diagnose Parkinson disease in early stages.
November 19th 2020, 10:16pm
In addition to different dosage forms of levodopa—the current standard of care for Parkinson disease—emerging trials are also examining alpha-synuclein, an abnormal protein that may be involved in the pathogenesis of the condition.
November 16th 2020, 8:00pm
A machine learning approach that works to identify mitochondrial impairments, a potential mechanism underlying the pathogenesis of Parkinson disease (PD), accurately distinguished between patients with PD and healthy controls.
November 13th 2020, 8:12pm
Patients with Parkinson disease (PD) who do not experience tremor were found to show improvements in reward learning after taking dopaminergic medication, while those with PD and tremor exhibited no benefit in reinforcement learning.
November 11th 2020, 10:29pm
Michael S. Fitts, assistant dean for user access and diversity at the University of Alabama at Birmingham, discusses misconceptions of Parkinson disease related to race and age, as well as advice for patients in their treatment journey.
November 6th 2020, 7:13pm
Individual-level low socioeconomic status (SES) was found to be significantly associated with increased mortality in Korean patients with Parkinson disease, whereas regional-level SES was not.
November 3rd 2020, 7:00pm
Researchers discuss the development and potential of stem cell–based therapies in the treatment of Parkinson disease.
October 29th 2020, 9:32pm
Michael S. Fitts, assistant dean for user access and diversity for The University of Alabama at Birmingham, discusses reporting on the progressive symptoms of Parkinson disease, and the impact of nonmotor symptoms of anxiety and depression.
